101 related articles for article (PubMed ID: 17459442)
1. Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.
Yang Y; Guo F; Cen S; Kleiman L
Virology; 2007 Aug; 365(1):92-100. PubMed ID: 17459442
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication.
Guo F; Cen S; Niu M; Saadatmand J; Kleiman L
J Virol; 2006 Dec; 80(23):11710-22. PubMed ID: 16971427
[TBL] [Abstract][Full Text] [Related]
3. Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
Henriet S; Mercenne G; Bernacchi S; Paillart JC; Marquet R
Microbiol Mol Biol Rev; 2009 Jun; 73(2):211-32. PubMed ID: 19487726
[TBL] [Abstract][Full Text] [Related]
4. Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.
Smith JL; Pathak VK
J Virol; 2010 Dec; 84(24):12599-608. PubMed ID: 20943965
[TBL] [Abstract][Full Text] [Related]
5. Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.
Wang X; Li X; Ma J; Zhang L; Ma L; Mi Z; Zhou J; Guo F; Kleiman L; Cen S
Virus Res; 2014 Oct; 191():30-8. PubMed ID: 25038404
[TBL] [Abstract][Full Text] [Related]
6. The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA.
Guo F; Cen S; Niu M; Yang Y; Gorelick RJ; Kleiman L
J Virol; 2007 Oct; 81(20):11322-31. PubMed ID: 17670826
[TBL] [Abstract][Full Text] [Related]
7. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN; Holmes RK; Malim MH
J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.
Holmes RK; Koning FA; Bishop KN; Malim MH
J Biol Chem; 2007 Jan; 282(4):2587-95. PubMed ID: 17121840
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
Cho SJ; Drechsler H; Burke RC; Arens MQ; Powderly W; Davidson NO
J Virol; 2006 Feb; 80(4):2069-72. PubMed ID: 16439564
[TBL] [Abstract][Full Text] [Related]
10. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.
Ulenga NK; Sarr AD; Thakore-Meloni S; Sankalé JL; Eisen G; Kanki PJ
J Infect Dis; 2008 Aug; 198(4):486-92. PubMed ID: 18598197
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 reverse transcription initiation: a potential target for novel antivirals?
Abbink TE; Berkhout B
Virus Res; 2008 Jun; 134(1-2):4-18. PubMed ID: 18255184
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus 1 (HIV-1) virion infectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcription.
Carr JM; Coolen C; Davis AJ; Burrell CJ; Li P
Virology; 2008 Mar; 372(1):147-56. PubMed ID: 18037155
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome.
Ebrahimi D; Anwar F; Davenport MP
Retrovirology; 2012 Dec; 9():113. PubMed ID: 23256516
[TBL] [Abstract][Full Text] [Related]
14. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
Jin SY; Choi HY; Kim HS; Jung YT
Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
[TBL] [Abstract][Full Text] [Related]
15. APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription.
Li XY; Guo F; Zhang L; Kleiman L; Cen S
J Biol Chem; 2007 Nov; 282(44):32065-74. PubMed ID: 17855362
[TBL] [Abstract][Full Text] [Related]
16. Fully-spliced HIV-1 RNAs are reverse transcribed with similar efficiencies as the genomic RNA in virions and cells, but more efficiently in AZT-treated cells.
Houzet L; Morichaud Z; Mougel M
Retrovirology; 2007 May; 4():30. PubMed ID: 17474982
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.
Malinowsky K; Luksza J; Dittmar MT
Virology; 2008 Jun; 376(1):69-78. PubMed ID: 18400243
[TBL] [Abstract][Full Text] [Related]
18. Interactions of reverse transcriptase sequences in Pol with Gag and LysRS in the HIV-1 tRNALys3 packaging/annealing complex.
Saadatmand J; Guo F; Cen S; Niu M; Kleiman L
Virology; 2008 Oct; 380(1):109-17. PubMed ID: 18708237
[TBL] [Abstract][Full Text] [Related]
19. The ins and outs of HIV replication.
Gomez C; Hope TJ
Cell Microbiol; 2005 May; 7(5):621-6. PubMed ID: 15839891
[TBL] [Abstract][Full Text] [Related]
20. Nuclear import of APOBEC3F-labeled HIV-1 preintegration complexes.
Burdick RC; Hu WS; Pathak VK
Proc Natl Acad Sci U S A; 2013 Dec; 110(49):E4780-9. PubMed ID: 24248339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
